Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Pulmonary aspergillosis.

J F Tomee¹, T S van der Werf

¹Division of Allergology, Department of Internal Medicine, University Hospital Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands. j.f.c.tomee@int.azg.nl

The Netherlands Journal of Medicine

|November 14, 2001

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Isoniazid and rifampicin exposure during treatment in drug-susceptible TB.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2023

Same author

Population Pharmacokinetic Model and Optimal Sampling Strategies for Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis.

Antimicrobial agents and chemotherapy·2022

Same author

Clinical standards for drug-susceptible TB: putting patients first.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2022

Same author

Assessment of TB treatment on patient well-being.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2021

Same author

Reply to Van Daele et al., "Fluconazole Underexposure in Critically Ill Patients: a Matter of Using the Right Targets?"

Antimicrobial agents and chemotherapy·2021

Same author

Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill Patients.

Antimicrobial agents and chemotherapy·2020

Same journal

A diagnostic tool for self-poisoned patients: Analysis of gastric content and lavage fluids.

The Netherlands journal of medicine·2020

Same journal

Answer to Photoquiz A bone disorder with skin lesions.

The Netherlands journal of medicine·2020

Same journal

A bone disorder with skin lesions.

The Netherlands journal of medicine·2020

Same journal

Answer to Photoquiz A fascinating liver abscess.

The Netherlands journal of medicine·2020

Same journal

A fascinating liver abscess.

The Netherlands journal of medicine·2020

Same journal

Answer to Photoquiz A polyposis syndrome.

The Netherlands journal of medicine·2020

See all related articles

Aspergillus, a common airborne mold, can cause serious lung diseases including aspergillomas and invasive infections in vulnerable individuals. It also acts as a potent allergen, leading to conditions like Aspergillus asthma.

Area of Science:

Pulmonology
Mycology
Infectious Diseases

Background:

Aspergillus species are widespread environmental molds.
Inhalation of Aspergillus spores (conidia) or fragments is common.
Airway colonization by Aspergillus can lead to various pulmonary diseases in susceptible individuals.

Purpose of the Study:

To review the clinical presentations of pulmonary diseases caused by Aspergillus.
To focus on the clinical aspects of Aspergillus-related lung conditions.

Main Methods:

Literature review of clinical presentations of pulmonary aspergillosis.
Focus on clinical manifestations and outcomes.

Main Results:

Aspergillus can cause aspergillomas in patients with pre-existing lung cavities, potentially leading to hemoptysis.

Related Experiment Videos

Acute invasive aspergillosis is a life-threatening condition in immunocompromised or debilitated patients.

Aspergillus acts as a significant allergen, causing Aspergillus asthma and allergic bronchopulmonary aspergillosis.

Conclusions:

Pulmonary diseases caused by Aspergillus have diverse clinical presentations.
Recognition of these varied presentations is crucial for timely diagnosis and management.
Aspergillus poses a significant threat through both infection and allergic sensitization in the respiratory tract.